Close Menu

NEW YORK – Diagnostic firm Mologic and self-test designer BioSure said on Monday that they have partnered to produce a SARS-CoV-2 antibody self-test.

The test will combine Mologic's lateral flow assay with BioSure's self-test design, the companies said. It doesn't require training and offers results in 10 minutes from a drop of blood. The assay is currently undergoing final validations, the companies added.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


As worldwide COVID-19 cases continue to rise, there is a significant need to increase testing and population surveillance capacity.

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.